Objective: To clarify the relationship between cognitive Functional Independence Measure (FIM) and motor FIM gain. Methods: We examined 1,137 patients with stroke in a Kaifukuki rehabilitation ward. Both motor and cognitive FIM scores at admission were divided into six separate groups (three groups per parameter), and we then compared these groups with motor FIM gain as the objective variable. We also performed a multiple regression analysis using motor FIM gain as the objective variable. Results: In the groups where motor FIM scores at admission were 13-38 points and 39-64 points, motor FIM gain was significantly higher in individuals that had high cognitive FIM scores at admission. In the multiple regression analysis, we found that motor FIM gain increased by 0.889 points when cognitive FIM scores at admission increased by 1 point in patients whose motor FIM score at admission was between 13 and 34 points and whose cognitive FIM score at admission was between 5 and 14 points.
Conclusion:This study clarified the relationship between cognitive FIM scores at admission and motor FIM gain in individuals with stroke.
We herein report three cases of Parkinson's disease associated with difficulty in eyelid opening, referred to as apraxia of eyelid opening (AEO), which improved after aripiprazole treatment. In case 1, aripiprazole was administered as a psychiatric treatment. It proved to be effective in AEO with blepharospasm. In case 2 and case 3, the patients experienced AEO without blepharospasm, and a significant improvement was observed after aripiprazole treatment. In this study, the aripiprazole dosage ranged between 3 and 9 mg/day. This is the first report of aripiprazole as a potentially effective treatment for AEO in Parkinson's disease.
The difference between measured Nichijo-seikatsu-kino-hyokahyo (NSKH) score and predicted NSKH score derived from ADL is related to FIM gain. Jpn J Compr Rehabil Sci 2013; 4: 61-66. Purpose: To determine if the difference between measured Nichijo-seikatsu-kino-hyokahyo score (NSKH) and predicted NSKH score (measured NSKH-predicted NSKH) derived from the Functional Independence Measure (FIM) score is related to FIM gain, and whether it increases the predictive accuracy of FIM gain. Methods: We studied 102 stroke patients in the Kaifukuki rehabilitation ward with FIM scores at admission between 18 and 58. We analyzed whether a correlation exists between "measured NSKHpredicted NSKH" and "FIM gain", and performed a multiple regression analysis to predict FIM gain. Results: A significant negative correlation (correlation constant −0.275, p<0.01) was detected between measured NSKH-predicted NSKH and FIM gain. The adjusted R-square value increased by 0.101 after incorporating measured NSKH-predicted NSKH into the predictive equation for FIM gain, which included age and FIM score at admission.
Conclusion:This study demonstrates that measured NSKH-predicted NSKH correlates with FIM gain, and that measured NSKH-predicted NSKH is an index that increases the predictive accuracy of FIM gain.
We herein report the case of an 81-year-old woman with midbrain infarction causing pupil-sparing oculomotor nerve palsy with ipsilateral cerebellar ataxia. The lesion was located at the rostral end of the decussation of the superior cerebellar peduncle touching the dorsal side, further caudal and dorsal to causal lesions of Claude's syndrome, which presented as oculomotor palsy and contralateral cerebellar ataxia. This is the third report of midbrain infarction causing partial oculomotor nerve palsy with ipsilateral cerebellar ataxia. It may be possible to establish this entity as a new syndrome following the accumulation of more cases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.